R76.11
Nonspecific reaction to tuberculin skin test without active tuberculosis
Clinical Classification Guidelines
Inclusion Terms
- Abnormal result of Mantoux test
- PPD positive
- Tuberculin (skin test) positive
- Tuberculin (skin test) reactor
Excludes Type 1
- nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis (R76.12)
Medical Intelligence & Overview
A nonspecific reaction to a tuberculin skin test, coded as R76.11, indicates an abnormal skin response following a Mantoux test without evidence of active tuberculosis. This condition suggests prior exposure or immune response to mycobacteria but does not confirm active disease. It is often identified during routine screening and requires interpretation in context.
Causes & Symptoms
Clinical Causes: Previous exposure to Mycobacterium tuberculosis or related bacteria Previous BCG vaccination possibly leading to a positive skin test Immune response indicating latent infection or prior sensitization Other forms of nonspecific skin reactivity
Key Symptoms: Absence of active tuberculosis symptoms such as cough, weight loss, or fever Localized skin induration and erythema at the test site Possible mild itching or discomfort at the injection site No systemic signs of illness
Diagnostic & Treatment
Diagnosis Path: Diagnosis is based on skin testing results, specifically a positive Mantoux test, which is characterized by an area of induration measuring 10 mm or more. Since the reaction is nonspecific, additional assessments such as chest X-rays and medical history are necessary to exclude active disease. The interpretation considers prior BCG vaccination and previous TB exposure. Blood tests like interferon-gamma release assays (IGRAs) may also aid in differentiation.
Treatment Protocols: As this reaction indicates no active tuberculosis, treatment is typically not required. Management involves monitoring and further assessments if symptomatic or if suspicion of latent or active TB arises. Healthcare providers may recommend periodic screening and follow-up. In cases where latent TB infection is suspected, chemoprophylaxis options might be discussed, but this depends on individual risk factors and clinical judgment.
Clinical Advice & FAQs
Billing Guidance
Is R76.11 a billable ICD-10 code?
Yes, R76.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R76.11?
Clinical documentation must specify the nature of Nonspecific reaction to tuberculin skin test without active tuberculosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference